Samuel J. Galgano, M.D. completed his undergraduate training and medical school at Emory University in Atlanta, GA. He then completed his residency training in Diagnostic Radiology at the University of Alabama at Birmingham, during which he acted as Chief Resident in his final year. He completed fellowships in both Molecular Imaging and Therapeutics as well as Abdominal Imaging at the University of Alabama at Birmingham prior to joining the faculty at UAB. During his Abdominal Imaging fellowship, he was awarded an RSNA Fellow Research Grant for his work on PET/MRI for patients with prostate cancer and participated in the UAB Clinical Investigator Training Program.
Clinically, Dr. Galgano is a member of the Abdominal Imaging as well as Molecular Imaging and Therapeutics sections with expertise in CT, ultrasound, MRI, fluoroscopy, PET/CT, and PET/MRI. He is a member of the Academy for Radiology and Biomedical Imaging Research Council of Early Career Investigators in Imaging. His research interests include novel radiotracer use in PET/CT and PET/MRI for applications in genitourinary and gastrointestinal oncology with particular interest in prostate cancer and hepatocellular carcinoma. He is a regular member of the multidisciplinary prostate, pancreaticobiliary, genitourinary, and hepatobiliary tumor boards and serves on the UAB Comprehensive Cancer Center Protocol Review Committee and Genitourinary Oncology Working Group. He is passionate about resident and medical student education and has received awards for medical student education several times during his career. In 2018, he began to serve as Assistant Director for the Abdominal Imaging Fellowship at UAB and became the Fellowship Director in 2019. In 2020, he began to serve as Section Chief for Abdominal Imaging.
